BioMarin completes acquisition of Alesta subsidiary
BioMarin completed the acquisition of Alesta, which became a wholly owned subsidiary after the August 31, 2026 closing.
BioMarin completed the acquisition of Alesta, which is now a wholly owned subsidiary following the August 31, 2026 closing.Key Highlights:Original SEC Filing: BIOMARIN PHARMACEUTICAL INC [ BMRN ] - 8-K - Sep.
01, 2026This is an AI-powered summary.
It may contain inaccuracies.
Consider verifying imp…